http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2690677-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_813362c67be6641b75b69da9a0cce970 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4875 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4891 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-191 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-87 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-217 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-17 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-87 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 |
| filingDate | 2018-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a80908909459e358f31840ee4a134ad8 |
| publicationDate | 2019-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2690677-C1 |
| titleOfInvention | Stabilized composition possessing antiviral, anticancer, immunomodulatory, actoprotective, antimutagenic and antioxidant activity |
| abstract | FIELD: medicine. n SUBSTANCE: invention represents a stabilized composition possessing antiviral, anti-tumour, immunomodulatory, actoprotective, antimutagenic and antioxidant activity, which is an acid-fast capsule containing calcium stearate, aerosil, microcrystalline carboxymethylcellulose, starch, lactose, grape seed powder, mannitol and in low doses lyophilisates of human recombinant interferon gamma and tumour necrosis factor - thymosin alpha 1, with the following ratio of components, wt. %: lyophilisate of human recombinant interferon gamma with activity 10×10 6 IU/g 0.5–2.5, recombinant tumour necrosis factor-lyophilizate - thymosin alpha 1 with activity 10×10 6 UN/g 0.2–1.0, grape seed powder 20–30, calcium stearate 1.23–3.7, aerosil 0.6–1.8, microcrystalline carboxymethyl cellulose 6–14.1, starch 14.5–29.5, lactose 6–14, mannitol - balance. n EFFECT: use of the disclosed composition provides stabilizing effect of cytokines due to optimally selected composition of components and amount thereof, obtaining gamma-based human recombinant interferon and TNF-T of a stabilized composition having high anti-tumour, antiviral, antioxidant, immunomodulatory, actoprotective, antimutagenic activity, wider range of storage temperature of interferon gamma and TNF-T without loss of activity, minimal side effect. n 3 cl, 1 dwg, 3 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2794024-C1 |
| priorityDate | 2018-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 237.